Class action lawsuits
Neogen Corporation, a leading provider of genetics testing solutions, has been at the center of a class action lawsuit filed by investors alleging that the company made false and misleading statements about its integration process. Despite the company's initial assurances of a smooth integration, investors claim that they
Class action lawsuits
Purchasers of Hims common stock between April 29, 2025, and June 23, 2025, may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm, a global investor rights law firm, reminds investors of the important August 25, 2025, lead
Class action lawsuits
Shareholders of 3D Systems Corporation (NYSE: DDD) who purchased securities between August 13, 2024, and May 12, 2025, may be entitled to compensation due to allegedly false and misleading statements made by the company. A class action lawsuit has been filed, and a lead plaintiff must be appointed by August
Class action lawsuits
Sable Offshore Corp. (NYSE: SOC) has been the subject of a securities class action lawsuit filed on behalf of purchasers of the company's securities between May 19, 2025 and June 3, 2025, as well as those who purchased shares pursuant to the company's secondary public offering
Class action lawsuits
Alto Neuroscience, a biotech company specializing in brain health, is embroiled in a class action lawsuit regarding its initial public offering and subsequent stock sales. The lawsuit alleges that the company made false and misleading statements about its products, specifically ALTO-100, a treatment for major depressive disorder. The case is
Class action lawsuits
Purchasers of Centene Corporation's securities between December 12, 2024, and June 30, 2025, may be entitled to compensation due to allegedly misleading statements about the company's enrollment, morbidity rates, and revenue guidance. A class action lawsuit has been filed, and investors have until September 8, 2025,
Class action lawsuits
Rosen Law Firm, a global investor rights law firm, has issued a notice reminding investors of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) to take action regarding a class action lawsuit filed against the company. The lawsuit claims that throughout the Class Period, defendants made false and
Class action lawsuits
Purchasers of 3D Systems Corporation (NYSE: DDD) securities between August 13, 2024, and May 12, 2025, have until August 12, 2025, to seek compensation for losses incurred due to allegedly false and misleading statements made by the company. The Rosen Law Firm, a global investor rights law firm, is urging
Class action lawsuits
Purchasers of securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) between September 17, 2024 and May 26, 2025, may be entitled to compensation without payment of out-of-pocket fees or costs through a contingency fee arrangement. A class action lawsuit has been filed, and investors have until August 11, 2025, to join
Class action lawsuits
The Rosen Law Firm has filed a class action lawsuit on behalf of investors who purchased common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025, and June 23, 2025. The lawsuit claims that the company made false and misleading statements about its partnership with Novo
Class action lawsuits
A class action lawsuit has been filed against Centene Corporation, a US-based healthcare company, on behalf of investors who purchased securities during a specific period. The lawsuit alleges that defendants made false and misleading statements about the company's revenue guidance and adjusted earnings per share. Investors who purchased
Class action lawsuits
Western Asset, a manager of mutual funds, allegedly failed to warn investors about a lack of fair allocation of investment opportunities among various investment strategies, leading to artificially reduced prices of certain funds during the class period. A class action lawsuit has been filed on behalf of investors who purchased
